<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0">
<channel>
	<title>BioToday.com [新着ニュース]</title>
	<description>BioToday.comは医学情報、バイオテクノロジー、バイオベンチャー関連ニュースのデータベースです。</description>
	<link>http://www.biotoday.com/news.cfm</link>
	<managingEditor>biotoday@biotoday.com</managingEditor>
	<copyright>Copyright &#169; 2026 BioToday Ltd. All Rights Reserved.</copyright>
	<lastBuildDate>Fri, 26 Jun 2026 16:48:06 +0900</lastBuildDate>
	<language>ja</language>
	<docs>http://blogs.law.harvard.edu/tech/rss</docs>
	<item>
		<title>[医学] 提供者からの肝臓の質を表面全体の解析で把握する手段を開発</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110143&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110143&amp;ref=rss</guid>
		<author>biotoday@biotoday.com</author>
		<pubDate>Fri, 26 Jun 2026 16:48:06 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110143&amp;ref=rss</comments>
	</item>
	<item>
		<title>[医学] 鉄結合蛋白質トランスフェリンと化学療法の併用で白血病マウス生存が改善</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110142&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110142&amp;ref=rss</guid>
		<author>biotoday@biotoday.com</author>
		<pubDate>Fri, 26 Jun 2026 16:06:45 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110142&amp;ref=rss</comments>
	</item>
	<item>
		<title>[医学] コンゴ民主共和国でのエボラへのMapp/Gileadの抗ウイルス薬の臨床試験が始まる</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110141&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110141&amp;ref=rss</guid>
		<category>開発 / 臨床試験 / その他臨床試験</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Fri, 26 Jun 2026 15:42:14 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110141&amp;ref=rss</comments>
	</item>
	<item>
		<title>[企業] Ollin社がRocheのVabysmoに挑むDME/wAMD薬のPh3試験資金3億ドル超調達</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110140&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110140&amp;ref=rss</guid>
		<category>ビジネス / ファイナンス / 投資/融資</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Fri, 26 Jun 2026 14:58:02 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110140&amp;ref=rss</comments>
	</item>
	<item>
		<title>[医学] GLP-1薬使用患者に嗅覚や味覚の障害が多い</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110139&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110139&amp;ref=rss</guid>
		<author>biotoday@biotoday.com</author>
		<pubDate>Fri, 26 Jun 2026 13:50:00 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110139&amp;ref=rss</comments>
	</item>
	<item>
		<title>[企業] 自己免疫疾患を治療するT細胞差し向け薬の臨床試験開始資金をOblenio社が調達</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110138&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110138&amp;ref=rss</guid>
		<category>ビジネス / ファイナンス / 投資/融資</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Fri, 26 Jun 2026 11:47:31 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110138&amp;ref=rss</comments>
	</item>
	<item>
		<title>[企業] 大塚製薬のADHD薬centanafadineが不安症でもある患者相手のPh3b試験成功</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110137&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110137&amp;ref=rss</guid>
		<category>開発 / 臨床試験 / 第3相/ピボタル試験</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Fri, 26 Jun 2026 10:49:45 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110137&amp;ref=rss</comments>
	</item>
	<item>
		<title>[企業] Boehringer IngelheimがImmunaiと組んで癌/自己免疫疾患の新規T細胞標的を探す</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110136&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110136&amp;ref=rss</guid>
		<category>ビジネス / 対外交渉 / 企業間提携</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Fri, 26 Jun 2026 10:24:55 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110136&amp;ref=rss</comments>
	</item>
	<item>
		<title>[企業] 独Merck KGaAが試薬、分析機器、診断のBio-Techneをおよそ113億ドルで買う</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110135&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110135&amp;ref=rss</guid>
		<category>ビジネス / 対外交渉 / 合併/買収</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Fri, 26 Jun 2026 09:51:19 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110135&amp;ref=rss</comments>
	</item>
	<item>
		<title>[医学] rifampicin耐性結核にbedaquiline+delamanid込み6か月治療が定番9か月治療に比肩</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110134&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110134&amp;ref=rss</guid>
		<category>ジャーナル / 総合医学誌 / New England Journal of Medicine（NEJM）</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Fri, 26 Jun 2026 09:27:29 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110134&amp;ref=rss</comments>
	</item>
	<item>
		<title>[医学] NovartisのCAR-Tで再発/治療抵抗性B細胞リンパ腫患者3人に1人が10年寛解保つ</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110133&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110133&amp;ref=rss</guid>
		<category>ジャーナル / 総合医学誌 / New England Journal of Medicine（NEJM）</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Fri, 26 Jun 2026 08:13:38 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110133&amp;ref=rss</comments>
	</item>
	<item>
		<title>[医学] HighTide社の抗炎症薬HTD1801で2型糖尿病患者の血糖値が低下</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110132&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110132&amp;ref=rss</guid>
		<author>biotoday@biotoday.com</author>
		<pubDate>Thu, 25 Jun 2026 16:53:07 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110132&amp;ref=rss</comments>
	</item>
	<item>
		<title>[医学] カタコトになってしまったアルツハイマー病女性がサイロシビンで会話し始めた</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110131&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110131&amp;ref=rss</guid>
		<author>biotoday@biotoday.com</author>
		<pubDate>Thu, 25 Jun 2026 16:34:34 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110131&amp;ref=rss</comments>
	</item>
	<item>
		<title>[企業] IonisのAPOC3遺伝子mRNA分解薬Tryngolzaの急性膵炎リスク低下効能を米国承認</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110130&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110130&amp;ref=rss</guid>
		<category>開発 / 承認申請 / 承認取得</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Thu, 25 Jun 2026 15:44:13 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110130&amp;ref=rss</comments>
	</item>
	<item>
		<title>[企業] GileadのTrodelvyの3受容体陰性乳癌（TNBC）初治療用途2つを米国FDAが承認</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110129&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110129&amp;ref=rss</guid>
		<category>開発 / 承認申請 / 承認取得</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Thu, 25 Jun 2026 15:25:31 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110129&amp;ref=rss</comments>
	</item>
	<item>
		<title>[企業] HRに加えてHER2も陽性の乳癌患者へのPfizerのIbrance使用を米国FDAが承認</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110128&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110128&amp;ref=rss</guid>
		<category>開発 / 承認申請 / 承認取得</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Thu, 25 Jun 2026 11:29:39 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110128&amp;ref=rss</comments>
	</item>
	<item>
		<title>[医学] 抗PD-1薬投与のタイミングと生存改善を関連付けた試験報告をNatureが取り下げ</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110127&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110127&amp;ref=rss</guid>
		<author>biotoday@biotoday.com</author>
		<pubDate>Thu, 25 Jun 2026 11:08:02 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110127&amp;ref=rss</comments>
	</item>
	<item>
		<title>[企業] NovartisがAntaresと協力して取り付く島なしの標的狙いの癌治療に取り組む</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110126&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110126&amp;ref=rss</guid>
		<category>ビジネス / 対外交渉 / 企業間提携</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Thu, 25 Jun 2026 09:40:25 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110126&amp;ref=rss</comments>
	</item>
	<item>
		<title>[企業] LillyがAbbiskoとの更なる提携で1つと言わず複数の治療薬の取り組みを進める</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110125&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110125&amp;ref=rss</guid>
		<category>ビジネス / 対外交渉 / 企業間提携</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Thu, 25 Jun 2026 08:55:03 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110125&amp;ref=rss</comments>
	</item>
	<item>
		<title>[企業] Boehringer IngelheimがCombotopeと組んで癌に特有の糖鎖配置狙いの抗体を探す</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110124&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110124&amp;ref=rss</guid>
		<category>ビジネス / 対外交渉 / 企業間提携</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Thu, 25 Jun 2026 08:03:03 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110124&amp;ref=rss</comments>
	</item>
	<item>
		<title>[企業] Versantが作った心筋症薬開発会社を気が向いたら買う権利をMerck KGaAが取得</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110123&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110123&amp;ref=rss</guid>
		<category>ビジネス / 会社運営 / 新規事業・事業拡大</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Wed, 24 Jun 2026 16:18:36 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110123&amp;ref=rss</comments>
	</item>
	<item>
		<title>[企業] Corxel社の経口GLP-1薬がPh2試験で米国の肥えた成人の体重を11.5%減らした</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110122&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110122&amp;ref=rss</guid>
		<category>開発 / 臨床試験 / 第2相試験</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Wed, 24 Jun 2026 15:58:33 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110122&amp;ref=rss</comments>
	</item>
	<item>
		<title>[企業] Sangamo社が破産して正味全資産を競売〜Lillyとアステラス製薬がまず入札</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110121&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110121&amp;ref=rss</guid>
		<category>ビジネス / 対外交渉 / ライセンス || ビジネス / 会社運営 / 破産</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Wed, 24 Jun 2026 14:14:01 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110121&amp;ref=rss</comments>
	</item>
	<item>
		<title>[企業] Exelixis社のzanzalintinibが大腸癌Ph3試験の非肝臓転移患者枠で目標達成ならず</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110120&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110120&amp;ref=rss</guid>
		<category>開発 / 臨床試験 / 第3相/ピボタル試験</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Wed, 24 Jun 2026 10:57:22 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110120&amp;ref=rss</comments>
	</item>
	<item>
		<title>[企業] 前臨床段階の固形癌治療CDH6xCD3両取り抗体の中国外権利をK2社が手に入れる</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110119&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110119&amp;ref=rss</guid>
		<category>ビジネス / 対外交渉 / ライセンス</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Tue, 23 Jun 2026 16:33:38 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110119&amp;ref=rss</comments>
	</item>
	<item>
		<title>[企業] SK社がAI創薬のInsilico Medicine社と組んで中枢神経系（CNS）薬に取り組む</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110118&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110118&amp;ref=rss</guid>
		<category>ビジネス / 対外交渉 / 企業間提携</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Tue, 23 Jun 2026 16:05:31 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110118&amp;ref=rss</comments>
	</item>
	<item>
		<title>[企業] TL1A抗体のPh1試験を進めるBionyra社が1億6500万ドル調達と共に発足</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110117&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110117&amp;ref=rss</guid>
		<category>ビジネス / ファイナンス / 投資/融資</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Tue, 23 Jun 2026 15:30:50 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110117&amp;ref=rss</comments>
	</item>
	<item>
		<title>[企業] ALS薬のPh1b/2a試験を進めるNura Bio社が7380万ドル調達</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110116&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110116&amp;ref=rss</guid>
		<category>ビジネス / ファイナンス / 投資/融資</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Tue, 23 Jun 2026 14:30:25 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110116&amp;ref=rss</comments>
	</item>
	<item>
		<title>[企業] Lillyが手持ち化合物の1つをBioArctic社の技術を使って脳に届くようにする</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110115&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110115&amp;ref=rss</guid>
		<category>ビジネス / 対外交渉 / 企業間提携</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Tue, 23 Jun 2026 12:49:11 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110115&amp;ref=rss</comments>
	</item>
	<item>
		<title>[企業] Pfizerのインテグリンβ6標的ADC・sigvotatug vedotinの肺癌Ph3試験失敗</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110114&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110114&amp;ref=rss</guid>
		<category>開発 / 臨床試験 / 第3相/ピボタル試験</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Tue, 23 Jun 2026 11:29:44 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110114&amp;ref=rss</comments>
	</item>
	<item>
		<title>[企業] Regenxbio社のハンター症候群遺伝子治療を米国が一転して手持ちで十分と判断</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110113&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110113&amp;ref=rss</guid>
		<category>開発 / 承認申請 / 承認申請</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Tue, 23 Jun 2026 11:14:40 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110113&amp;ref=rss</comments>
	</item>
	<item>
		<title>[企業] Merck &amp; Coの抗TL1A抗体tulisokibartの潰瘍性大腸炎Ph3試験ATLAS-UC目標達成</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110112&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110112&amp;ref=rss</guid>
		<category>開発 / 臨床試験 / 第3相/ピボタル試験</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Tue, 23 Jun 2026 10:07:27 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110112&amp;ref=rss</comments>
	</item>
	<item>
		<title>[企業] Definium社の気の持ちようを変える薬DT120の大うつ病（MDD）Ph3試験成功</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110111&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110111&amp;ref=rss</guid>
		<category>開発 / 臨床試験 / 第3相/ピボタル試験</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Tue, 23 Jun 2026 09:43:32 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110111&amp;ref=rss</comments>
	</item>
	<item>
		<title>[企業] はたしてAbbVieがApogee社を109億ドルで買う</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110110&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110110&amp;ref=rss</guid>
		<category>ビジネス / 対外交渉 / 合併/買収</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Tue, 23 Jun 2026 08:25:26 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110110&amp;ref=rss</comments>
	</item>
	<item>
		<title>[企業] CARsgen社の固形癌治療CAR-T/satricabtagene autoleucel（satri-cel）を中国承認</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110109&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110109&amp;ref=rss</guid>
		<category>開発 / 承認申請 / 承認取得</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Tue, 23 Jun 2026 07:31:25 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110109&amp;ref=rss</comments>
	</item>
	<item>
		<title>[医学] 低濃度アトロピン点眼が小児の近眼の進行を遅らせた</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110108&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110108&amp;ref=rss</guid>
		<category>ジャーナル / 総合医学誌 / BMJ</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Mon, 22 Jun 2026 16:49:20 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110108&amp;ref=rss</comments>
	</item>
	<item>
		<title>[医学] 血管新生加齢黄斑変性症（nAMD）に定位放射線治療（SRT）をしてはいけない</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110107&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110107&amp;ref=rss</guid>
		<category>ジャーナル / 総合医学誌 / BMJ</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Mon, 22 Jun 2026 16:18:14 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110107&amp;ref=rss</comments>
	</item>
	<item>
		<title>[医学] ビタミンDの類いパリカルシトールと化学療法の組み合わせが膵癌患者により有効</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110105&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110105&amp;ref=rss</guid>
		<author>biotoday@biotoday.com</author>
		<pubDate>Mon, 22 Jun 2026 15:44:22 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110105&amp;ref=rss</comments>
	</item>
	<item>
		<title>[医学] 【増補版】薬での体冷却で脳卒中後の脳損傷を減らせるかもしれない</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110106&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110106&amp;ref=rss</guid>
		<author>biotoday@biotoday.com</author>
		<pubDate>Mon, 22 Jun 2026 11:22:26 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110106&amp;ref=rss</comments>
	</item>
	<item>
		<title>[医学] 12-18歳でHPVワクチンを接種した英国イングランド女性の子宮頸癌死がほぼ消失</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110104&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110104&amp;ref=rss</guid>
		<author>biotoday@biotoday.com</author>
		<pubDate>Sun, 21 Jun 2026 16:58:12 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110104&amp;ref=rss</comments>
	</item>
	<item>
		<title>[企業] Tune社の慢性B型肝炎薬TUNE-401のPh1b/2a試験成績が有望</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110103&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110103&amp;ref=rss</guid>
		<category>開発 / 臨床試験 / 第1相試験</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Sun, 21 Jun 2026 16:23:11 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110103&amp;ref=rss</comments>
	</item>
	<item>
		<title>[医学] 血中NAD+濃度は老化の指標にならないらしい</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110102&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110102&amp;ref=rss</guid>
		<author>biotoday@biotoday.com</author>
		<pubDate>Sun, 21 Jun 2026 10:52:14 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110102&amp;ref=rss</comments>
	</item>
	<item>
		<title>[医学] 脳全域のグリンパティック系を光音響色素を使って切った張ったせず見る術開発</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110101&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110101&amp;ref=rss</guid>
		<author>biotoday@biotoday.com</author>
		<pubDate>Sun, 21 Jun 2026 10:15:58 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110101&amp;ref=rss</comments>
	</item>
	<item>
		<title>[医学] 老いたマウスの脳の可塑性が若い衆の糞中微生物移植で改善</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110100&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110100&amp;ref=rss</guid>
		<author>biotoday@biotoday.com</author>
		<pubDate>Sun, 21 Jun 2026 08:50:08 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110100&amp;ref=rss</comments>
	</item>
	<item>
		<title>[医学] 精子を磁石で導いて受精させる手段を開発</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110099&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110099&amp;ref=rss</guid>
		<author>biotoday@biotoday.com</author>
		<pubDate>Sat, 20 Jun 2026 16:27:22 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110099&amp;ref=rss</comments>
	</item>
	<item>
		<title>[企業] アトピー性皮膚炎薬がPh2試験好成績のApogee社をAbbVieが買う交渉中らしい</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110098&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110098&amp;ref=rss</guid>
		<category>ビジネス / 対外交渉 / 合併/買収</category>
		<author>biotoday@biotoday.com</author>
		<pubDate>Sat, 20 Jun 2026 10:45:23 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110098&amp;ref=rss</comments>
	</item>
	<item>
		<title>[医学] 移植腎臓を与える人の骨髄と受け取る人のTregの投与で免疫寛容を引き出しうる</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110097&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110097&amp;ref=rss</guid>
		<author>biotoday@biotoday.com</author>
		<pubDate>Fri, 19 Jun 2026 17:08:09 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110097&amp;ref=rss</comments>
	</item>
	<item>
		<title>[医学] EGFRとMETのどちらも阻害することが扁平上皮化肺癌に有効らしい</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110096&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110096&amp;ref=rss</guid>
		<author>biotoday@biotoday.com</author>
		<pubDate>Fri, 19 Jun 2026 16:42:09 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110096&amp;ref=rss</comments>
	</item>
	<item>
		<title>[医学] IL-17A阻害が癌患者の静脈血栓塞栓症の予防法となりうる</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110095&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110095&amp;ref=rss</guid>
		<author>biotoday@biotoday.com</author>
		<pubDate>Fri, 19 Jun 2026 15:37:51 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110095&amp;ref=rss</comments>
	</item>
	<item>
		<title>[医学] 多剤耐性淋菌を阻止する化合物2つを発見</title>
		<description></description>
		<link>http://www.biotoday.com/view.cfm?n=110094&amp;ref=rss</link>
		<guid>http://www.biotoday.com/view.cfm?n=110094&amp;ref=rss</guid>
		<author>biotoday@biotoday.com</author>
		<pubDate>Fri, 19 Jun 2026 15:01:41 +0900</pubDate>
		<comments>http://www.biotoday.com/post_comment.cfm?init=A110094&amp;ref=rss</comments>
	</item>
</channel>
</rss>
